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Abstract. Bacteriophages are viruses infecting bacteria and archaea. Many phage species cause in-
fections which lead to the certain death of the infected prokaryotic host cell and the release of a large
batch of phage progeny, yet they have been able to stably coexist with their bacterial hosts over the
eons in nature, as well as in the majority of laboratory experiments reported in the literature. This
possibility of a stable coexistence between populations of bacteria and bacteriophages can be suspected
to critically reduce the chances of a successful therapeutic application of bacteriophages for combatting
pathogenic bacterial infections in vivo. Here, we extend an established differential equation model de-
scribing the interaction of bacteria, bacteriophages, and the host immune system, modelling different
degrees of spatial heterogeneity of the host organism by introducing a scaling parameter which alters
the encounter rates of the different cell populations. We demonstrate by rigorous mathematical analysis
that, depending on the degree of spatial heterogeneity, the system will either converge to the desired
state of bacterial and phage extinction, to a state of persisting bacterial infection with a completely
eliminated bacteriophage population or to an equally undesirable state of a stable long-term bacteria-
bacteriophage coexistence. We additionally provide numerical solutions of the model to illustrate the
emerging dynamics and discuss some implications for bacteriophage therapy.
1. Introduction
Bacteriophages are viruses that infect and replicate within bacteria and archaea. They can either have
only a lytic lifecycle or both a lytic and a lysogenic one. In case of a lytic life cycle, the genome of
the bacteriophage is replicated and expressed as proteins within the bacterial host cell after a successful
infection. After the assemblage of the virions, the host cell is lysed and the assembled particles are
released. In contrast, in case of a lysogenic life cycle the virus persists as a prophage by integrating
into the host genome or is maintained extrachromosomally in the host cell (Brock et al., 2003). A third
developmental route, called ’pseudolysogeny’, has also been proposed, in which the lysis of the host cell
is postponed over the course of one or more host generations without the formation of a prophage, which
primarily seems to occur in cases of nutrient-depleted host cells (Clokie et al., 2011). As pointed out
by Heilmann et al. (2012), many phage species solely rely on a virulent lifecycle, causing any infection
to lead to the certain death of the infected host cell and the release of a large batch of phage progeny.
Consequently, it is a bewildering question how such voracious parasites have been able to stably co-
exist with their bacterial hosts over the eons. Adding to one’s astonishment, in the great majority of
experimental studies reported in the literature, a long-term persistence of the phage population in a
mixed bacteria-bacteriophage culture could be observed (for example, refer to Horne (1970), Chao et al.
(1977) or Lenski and Levin (1985)), while cases of phage extinction are in fact rather rare (Bohannan
and Lenski, 2000).
E-mail address: m.m.fischer@fu-berlin.de.
Date: December 24, 2019.
1
ar
X
iv
:1
91
2.
10
44
6v
1 
 [q
-b
io.
PE
]  
22
 D
ec
 20
19
2 PERSISTENCE OF LYTIC BACTERIOPHAGES IN VIVO
Bacteriophages have been proposed as a possible way of treating pathogenic bacterial infections in hu-
mans or animals since the mid of the last century (Keen, 2012), because they offer a number of advantages
over classical antibiotic therapy: By virtue of being significantly more specific to their bacterial hosts
than antibiotics, they can be expected to be generally harmless to the patient as well as the microbiomes
of the patients, and to have a lower amount of undesirable side effects (Bruttin and Bru¨ssow, 2005;
Rhoads et al., 2009). Due to the increasing rates of bacterial resistances towards established antibiotics
(Liljeqvist et al., 2012; Holmes et al., 2016), as well as the steady decline in the numbers of newly ap-
proved antibiotics (Hughes, 2011; Jackson et al., 2018), bacteriophage therapy has again become a focus
of attention in biomedical research – for an example of a recent clinical trial refer to Wright et al. (2009).
Nonetheless, the possibility of a stable coexistence between populations of bacteria and bacteriophages,
as outlined previously, may in some cases very well be able to critically reduce the chances of a success-
ful therapeutic application of bacteriophages in vivo. Accordingly, understanding the exact mechanisms
enabling such a coexistence can be expected to be of great importance for a successful clinical translation.
Generally, two major reasons for the possibility of such a long-term coexistence between host and par-
asite have been proposed: First, a coevolution between the two interacting populations in the form of
an ’evolutionary arms-race’, or, put more formally, a reciprocal genetic change in interacting species,
owing to natural selection imposed by each on the other (Futuyma et al., 2005). This has been studied
e.g. by Weitz et al. (2005) using sets of differential equations extended by an event-driven system based
on random numbers, where traits of the interacting organisms were varied, and for every newly arising
genotype, a new equation was added to the system. They were able to show that multiple strains of
bacteria and bacteriophages can permanently coexist in a homogeneous medium with a single resource
and that diversification leads to different genotypes of phages that adsorb effectively to only a limited
subset of all existent bacterial genotypes. In other words, functional differences between bacterial and
viral genotypes will arise endogenously within the simulated cocultures.
The other proposed mechanism enabling such a stable coexistence refers to effects of the spatial environ-
ment on the interacting populations. In case of a typical continuous bacteria-bacteriophage coculture
taking place in a well-mixed chemostat system, this is primarily possible due to the formation of a bac-
terial biofilm on the inside of the reaction vessel, in which so-called wall populations can persist next
to the populations in the planktonic phase. This has for example been experimentally demonstrated by
Schrag and Mittler (1996) who showed that cocultures with bacterial wall populations allowed long-term
coexistence in contrast to cocultures taking place in a completely homogeneous planktonic system. They
also demonstrated that the final percentage of sensitive bacteria was significantly higher in walls than in
liquid populations, concluding that biofilms on glass surfaces may also act as spatial refuges for bacteria
with a genotype not resistant to bacteriophage infection. In addition to acting as a refuge for sensitive
bacteria, the complex spatial microstructure of biofilms can be assumed to directly influence the infection
likelihood per host encounter and the diffusion ability of phages. This has, for example, been suggested
by the experimental results of Brockhurst et al. (2006) who studied the interaction between the bacte-
riophage PP7 and the bacterium Pseudomonas aeruginosa in spatially heterogeneous cultures. A study
by Luckinbill (1973) on the interaction of Paramecium aurelia and its predator Didinium nasutum has
further substantiated this idea by demonstrating that the two populations were able to coexist if and only
if methyl cellulose was added to the growth medium leading to slower dispersal of the organisms, thereby
causing lower encounter rates of predator and prey species. The same has already been pointed out by
Simmons et al. (2018) who derived an agent-based simulation framework of the bacteria-bacteriophage
interaction in a growing biofilm. They determined the phage mobility in the biofilm phase as one of
the core determinants for a long-term stable coexistence and demonstrated that the probability of a
successful elimination of the bacterial population significantly decreases if phage mobility in the biofilm
phase is reduced. Since the authors modelled the interaction in an in vitro culture, these results might
not be completely transferable to the medically relevant in vivo case, where additional effects of the host
immune systems are at play. Additionally, the results of such agent-based simulations should primarily
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be understood as a set of observations on a series of in silico experiments, lacking the inherent strengths
of traditional mathematical models which allow to definitely ’prove’ the observed relationships (Ermen-
trout and Edelstein-Keshet, 1993).
Hence, in this work we provide a rigorous mathematical analysis based on an established differential
equation model by Leung and Weitz (2017) describing the in-vivo interaction of a bacterial and a bac-
teriophage population as well as the innate host immune system of the infected organism. We implicitly
model different degrees of spatial heterogeneity and the complexity of the spatial microstructure of the
system by introducing a scaling parameter which alters the encounter rates of the different cell popula-
tions. We calculate the occurring equilibrium states of the system and assess their asymptotic stability
for varying values of this scaling parameter, and will demonstrate that the degree of spatial heterogeneity
crucially affects the qualitative behaviour of the system: Depending on the degree of spatial heterogene-
ity, the system will either converge to the desired state of bacterial and phage extinction, to the state of
a persisting bacterial infection with a completely eliminated bacteriophage population or to a state of a
stable long-term bacteria-bacteriophage coexistence.
2. Materials and methods
2.1. Mathematical model. We base our analysis on an established model by Leung and Weitz (2017).
Since we are mainly interested in the potential application of bacteriophages as a means of treating
bacterial infections which cannot be dealt with by the immune system of the host alone, we can assume
that the density of immune cells I(t) has already grown to the maximum possible value of KI , so that
I(t) = KI = const. This reduces their three-dimensional system to a two-dimensional one, describing
the rates of change of the bacteria and phage population densities as follows:
B˙(t) =
KB −B(t)
KB
rB(t)− σΦB(t)P (t)− σB(t)KI/
(
1 +
B(t)
KD
)
P˙ (t) = βσΦB(t)P (t)− ωP (t)
(2.1)
where KB ,KI describe the maximum carrying capacity of the host for the bacterial and the immune
cell population, respectively. The maximum growth rate of the bacterial population is termed r; the
constant KD describes the bacterial cell concentration at which the immune response is half saturated
to account for the immune evasion at higher bacterial concentrations. Following the original paper, the
phage adsorption rate is labelled Φ and the killing rate of the immune system is termed . The effective
viral burst size is denoted with β, and ω denotes the phage clearance rate in vivo. For the estimated
values of the parameters refer to Table 3 in the original paper. We have also added a scaling parameter
σ as an additional factor to all encounter rates which we will manipulate later in order to simulate
different levels of spatial heterogeneity. For σ = 1 the system is equivalent to the model presented in the
original paper, while decreasing the parameter reduces the rates with which the different cell populations
encounter each other.
2.2. Numerical solutions. Numerical solutions of the system were obtained using the Python pro-
gramming language, version 3 (Van Rossum and Drake Jr, 1995), and the command solve ivp in the
Python software package SciPy (Jones et al., 2001). All plots in this paper have been generated using
the matplotlib software library for Python (Hunter, 2007).
3. Results
3.1. Analytical examination. We limit our search for steady states to the biologically feasible region,
where the three variables are all equal or greater than zero. Three such equilibria can be found: First,
the state of extinction E with B¯ = P¯ = 0. Second, the phage-free equilibrium F with
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B¯ = −KC +KD
2
+
√
(KC −KD)2
4
+KCKD
(
1− σKI
r
)
; P¯ = 0. (3.1)
From B¯ one may conclude that meaningful solutions only arise for σ ≤ r4KI
(
KC
KD
+ KDKC +
2
r
)
≈ 58.0.
Third, the coexistence state C with
B¯ =
ω
βσΦ
; P¯ =
r
σΦ
(
1− ω
βσΦKB
)
− KIω
βσKD
+ Φ
, (3.2)
which importantly only yields feasible solutions for P¯ if σ ∈ [2 × 10−4; 0.587] under the standard
parametrisation. Thus, a coexistence equilibrium starts to exist for a spatial scaling parameter of 0.587
or below.
The Jacobian of the system is given by
J =
− 2rKB(t)− σΦP (t)− σK2DKI(B(t)+KD)2 + r −σΦB(t)
βσΦP (t) βσΦB(t)− ω
 , (3.3)
which at the extinction state E has the eigenvalues λ1 = r − σKI and λ2 = −ω. Accordingly, the
extinction state is stable as long as the scaling parameter σ > rKI ≈ 0.508. This makes sense biolog-
ically as infections with small amounts of bacteria can normally easily be dealt with by the immune
system, which makes the disease-free state biologically stable in praxis. Importantly, however, in case
of increasing spatial complexity, e.g. due to the formation and growth of a biofilm or due to multiple
compartments being involved in the infection, the extinction state loses its stability.
At the phage-free equilibrium F , we get the two eigenvalues
λ1 = −2r
K
B¯ + r − σK
2
DKI
(B¯ +KD)2
; λ2 = βσΦB¯ − ω. (3.4)
One can easily show that under the standard parametrisation of the model, the first eigenvalue will stay
below zero even for drastic changes in σ spanning over several orders of magnitude. However, the second
eigenvalue is crucially affected by the choice of σ. Figure 1 shows the real parts of the eigenvalues using
the standard parametrisation introduced earlier as a function of the scaling parameter σ. Observe that
given a sufficiently small scaling factor σ, the phage-free equilibrium will become stable, indicating a
persistent bacterial infection which the host immune system cannot take care of. We do not show the
imaginary part of the Jacobian here, as it is constantly equal to zero, which makes the equilibrium state
a stable node or a saddle point respectively.
Finally, at the coexistence state C we get complicated expressions for the eigenvalues which we omit
here for brevity purposes. Figure 2 shows the real and imaginary parts of the two eigenvalues of the
Jacobian of the system at the coexistence state. Note the existence of a range of values for σ, in which
the real parts of both eigenvalues fall below zero, indicating the local stability of the state of bacteria-
bacteriophage coexistence in the form of a stable spiral. For bigger values of the parameter, this spiral
will become unstable until it finally vanishes at σ ≥ 0.587.
3.2. Representative phase portraits. We now show representative phase portraits for different values
of the spatial scaling parameter σ in order to illustrate the resulting system. Figure 3 shows the resulting
phase space for a scaling parameter of σ = 1, i.e. for the standard parametrisation. The phage-free state
of bacterial infection is asymptotically unstable towards perturbations in the phage density (top-left
plot, black circle), however the extinction state is stable (bottom-left plot, black disc). The state of
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coexistence does not yet exist due to σ being greater than 0.587, causing the B-nullcline (vertical blue
line) to fall into the second quadrant. Accordingly, a bacterial infection can be treated by introducing a
sufficient amount of bacteriophages into the system.
Figure 4 shows the resulting phase space for a scaling parameter of σ = 10−3. The phage-free state of
bacterial infection is still asymptotically unstable towards perturbations in the phage density (top-left
plot, black circle), however the extinction state now has lost its stability due to σ being less than 0.508
(bottom-left plot, black circle). A new state of coexistence in the form of a stable spiral has now appeared
(black disc on the right-hand side at the intersection of the two nullclines), since σ now falls below the
critical value of 0.508. Accordingly, the introduction of bacteriophages will now shift the system from a
state of bacterial infection to a state of stable bacteria-bacteriophage coexistence.
Finally, figure 5 depicts the phase space for σ = 10−4. The state of phage-free bacterial infection is now
stable (top-left plot, black disc), while the extinction state is unstable just as before (bottom-left plot,
black circle). The state of stable coexistence now has vanished from the biologically meaningful first
quadrant, since σ has fallen below the critical value of 2×10−4. Accordingly, the bacterial infection now
is persistent and cannot be treated by bacteriophage therapy anymore.
3.3. Numerical solutions of the model. To illustrate the emerging dynamics of the system, we will
now provide a number of numerical simulations of the derived model. In contrast to the simulations
provided in Leung and Weitz (2017), we here assume the medically more meaningful scenario, in which
the bacterial population density inside the host organism, as well as the immune response of the host
have already reached the maximum value. We now add an inoculum of 105 bacteriophages per millilitre
into the host organism in order to try to combat the bacterial infection. Figure 6 depicts the emerging
dynamics for the same values of the spatial scaling parameter σ as used in the previous section. The
simulations confirm what an inspection of the phase portraits has already suggested: Depending on
the degree of spatial complexity, the system will converge to one of the three equilibria respectively.
It is again especially noteworthy that for a sufficiently high degree of complexity an eradication of the
bacterial infection is not possible and instead either a stable coexistence of bacterium and phage will
take place, or the bacteriophage population is eliminated from the system, while the bacterial infection
persists.
4. Discussion
In this work, we have extended a simple and elegant ODE model by Leung and Weitz (2017) to assess
the influence of the spatial microstructure of a host organism on the in vivo interaction of bacteria,
bacteriophages and the host immune system. The degree of complexity of the spatial microstructure was
modelled by introducing a scaling parameter which linearly scales the encounter rates between the three
populations, making use of observations by Luckinbill (1973). This approach is especially appropriate
in the light of the ability of bacteria to form biofilms – hydrated matrices of extracellular polymeric
substances with low diffusivity (Reisner et al., 2003), however the scaling parameter can also simply be
thought of a parameter describing the general degree of spatial heterogeneity of the system. We have
demonstrated changes in the qualitative behaviour of the system depending on this degree of complexity,
namely the emergence of a stable equilibrium of long-term bacteria-bacteriophage coexistence, as well as
the possibility of a stable bacterial infection not treatable by bacteriophage therapy.
Our results point into the same direction as the experimental work of Brockhurst et al. (2006) and an-
alytically confirm and extend the results of the extensive agent-based simulations of the in-vitro case
by Simmons et al. (2018), however offer the advantage of a simple, analytically examinable mechanistic
mathematical model. It is especially noteworthy that the model presented in this work does not include
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any evolutionary processes such as the emergence of new genotypes. Accordingly, the stable states of
coexistence does not seem to necessarily require any coevolutionary dynamics between the interacting
populations, which, however, seem to be necessary for long-term coexistence in completely homogeneous
environments as demonstrated by Weitz et al. (2005). This finding is in agreement with the results of a
recent work by Lourenc¸o et al. (2019) who found that the natural coexistence of bacteria and phages in
the mouse gut was neither dependent on an arms race between bacteria and phages, nor on the ability
of phages to extend host range. Instead, they identified the spatial heterogeneity of the organ to be the
core determinant of long-term coexistence.
The results of this study may also be understood as the examination of a mechanism that is possibly able
to reduce the efficacy of bacteriophage therapy for the treatment of bacterial infections. Due to the high
degree of spatial heterogeneity of eukaryotic organisms as well as the ability of bacteria to form biofilms,
bacteriophage therapy might, in some cases, not eradicate the bacterial infection as desired, or lead to an
undesirable stable long-term coexistence of bacteria and a bacteriophage populations in the patient. This
can be expected to become especially relevant in case of complicated systemic infections, where multiple
compartments of the host organism are affected. The fact that the exposure of bacteria to phages is also
able to stimulate bacterial biofilm production as reviewed by Hansen et al. (2019) may further complicate
the matter, as well as interactions between the host immune system and bacteriophages which might
increase the degradation rates of the latter, thereby decreasing their efficacy for controlling the bacterial
infection of the host organism (Dkabrowska, 2018; Krut and Bekeredjian-Ding, 2018).
An interesting property of some bacteriophages is their ability to break down biofilms by carrying surface
enzymes which can degrade bacterial polysyccharids (Bayer et al., 1979), which appears to be a promising
starting point to deal with the problem of biofilm-induced spatial heterogeneity in bacteriophage therapy.
(For a more extensive review on the topic of bacteriophage-biofilm interaction, refer to Sutherland et al.
(2004).) As one might expect, the concentration of phage inoculum crucially influences the degree of
biofilm disruption observable in vitro, however even a high multiplicity of infection of 100 does not
seem to guarantee bacterial extinction, but can still lead to a stable coexistence of phage and bacterium
instead (Corbin et al., 2001). Additionally, viral surface depolymerases have been found to be rather
specific and usually only able to target only a few, closely related bacterial polysaccharide structures
(Sutherland, 1999, 1995). Finally, biofilms which consist of multiple bacterial species, can be expected to
be more resistant to bacteriophage exposure than single species ones, as demonstrated in a study by Tait
and Sutherland (2002), which might be caused by additional structural heterogeneity within the biofilm.
Experimental studies attempting to use phages to control bacterial biofilms in vivo do not seem to have
unanimously yielded promising results yet (Kudva et al., 1999; Sklar and Joerger, 2001), and one may
reasonably assume that in some cases other means of controlling chronic bacterial infections which have
produced biofilms in vivo may be required. Nonetheless, for some applications such as the treatment of
locally confined chronic infections which are easily accessible from the outside, such as chronic diabetic
ulcers, bacteriophage therapy indeed seems to be a promising approach (Morozova et al., 2018).
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5. Display items
Figure 1. Real parts of the two eigenvalues of the Jacobian at the phage-free equilibrium
for different values of the scaling factor σ. Observe how this state of eradication of the
phage population becomes stable for a sufficiently small value of σ. Imaginary parts of
zero not shown.
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Figure 2. Real and imaginary parts of the two eigenvalues of the Jacobian at the coex-
istence equilibrium for different values of the scaling factor σ. The range of the x-axis
is confined to the region in which the coexistence state C exists and has positive solutions.
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Figure 3. Phase portrait of the system for σ = 1.0. Black discs indicate stable equi-
libria, black circles unstable ones. Vertical blue line: non-trivial B-nullcline, horizontal
orange line: non-trivial P-nullcline. Note that the non-trivial B-nullcline slightly falls
into the second quadrant of the plot, which is the reason why it cannot be seen in the
bottom left-hand side plot.
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Figure 4. Phase portrait of the system for σ = 10−3. Black discs indicate stable equi-
libria, black circles unstable ones. Diagonal blue line: non-trivial B-nullcline, horizontal
orange line: non-trivial P-nullcline.
Figure 5. Phase portrait of the system for σ = 10−4. Black discs indicate stable equi-
libria, black circles unstable ones. Diagonal blue line: non-trivial B-nullcline, horizontal
orange line: non-trivial P-nullcline.
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Figure 6. Numerical solutions of the system for different values of the spatial scaling
parameter σ. The numerical approximations confirm what an inspection of the phase
portraits has already suggested: With increasing spatial complexity, bacteriophages will
not be able to eliminate the bacterial infection anymore, but will instead coexist stably
with the bacteria (middle plot) or will be eliminated (right plot).
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